MedTrace Logo

Scorpio® Cruciate Retaining (CR) Outcomes Study

NCT00965146 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 215

Last updated 2017-11-17

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the design and functional performance of the Scorpio® Cruciate Retaining (CR) Total Knee System.

Conditions

  • Arthropathy of Knee

Interventions

DEVICE

Scorpio® CR Total Knee System

All subjects will be implanted with a femoral component, a tibial insert, a tibial tray and a resurfaced patella.

Sponsors & Collaborators

  • Stryker Orthopaedics

    lead INDUSTRY

Principal Investigators

  • C. Lowry Barnes, MD · Foundation for Musculoskeletal Research and Education

  • Lawrence Morawa, MD · Dearborn Orthopaedics

  • Arthur Malkani, MD · Jewish Physician Group

  • Frank Kolisek, MD · Orthopaedic Research Foundation, Inc.

  • Steven Harwin, MD · Beth Israel Medical Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-06-30
Primary Completion
2009-07-23

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00965146 on ClinicalTrials.gov